WoodTrust Financial Corp Makes New $295,000 Investment in The Cigna Group (NYSE:CI)

WoodTrust Financial Corp bought a new position in shares of The Cigna Group (NYSE:CI) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 813 shares of the health services provider’s stock, valued at approximately $295,000.

Several other large investors have also recently bought and sold shares of CI. Norges Bank acquired a new stake in The Cigna Group in the fourth quarter valued at $1,006,348,000. Cerity Partners LLC raised its holdings in shares of The Cigna Group by 1,039.4% in the 4th quarter. Cerity Partners LLC now owns 590,063 shares of the health services provider’s stock valued at $176,694,000 after purchasing an additional 538,274 shares during the period. Jennison Associates LLC lifted its stake in The Cigna Group by 127.3% in the 4th quarter. Jennison Associates LLC now owns 566,233 shares of the health services provider’s stock valued at $169,558,000 after purchasing an additional 317,081 shares during the last quarter. International Assets Investment Management LLC grew its holdings in The Cigna Group by 21,324.4% during the fourth quarter. International Assets Investment Management LLC now owns 285,801 shares of the health services provider’s stock worth $85,583,000 after purchasing an additional 284,467 shares during the period. Finally, Assenagon Asset Management S.A. grew its holdings in The Cigna Group by 153.6% during the fourth quarter. Assenagon Asset Management S.A. now owns 386,226 shares of the health services provider’s stock worth $115,655,000 after purchasing an additional 233,945 shares during the period. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at The Cigna Group

In related news, SVP Hoeltzel Mary T. Agoglia sold 5,946 shares of the company’s stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $348.71, for a total transaction of $2,073,429.66. Following the completion of the transaction, the senior vice president now directly owns 2,595 shares in the company, valued at approximately $904,902.45. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other news, insider Brian C. Evanko sold 4,795 shares of The Cigna Group stock in a transaction dated Monday, June 24th. The stock was sold at an average price of $345.01, for a total transaction of $1,654,322.95. Following the sale, the insider now directly owns 39,923 shares of the company’s stock, valued at $13,773,834.23. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Hoeltzel Mary T. Agoglia sold 5,946 shares of the company’s stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $348.71, for a total value of $2,073,429.66. Following the completion of the transaction, the senior vice president now directly owns 2,595 shares of the company’s stock, valued at approximately $904,902.45. The disclosure for this sale can be found here. Insiders have sold a total of 22,988 shares of company stock worth $7,975,726 over the last 90 days. Insiders own 0.60% of the company’s stock.

The Cigna Group Price Performance

CI stock traded down $3.58 during mid-day trading on Friday, hitting $330.57. The stock had a trading volume of 2,645,258 shares, compared to its average volume of 1,508,288. The firm has a fifty day simple moving average of $341.23 and a 200 day simple moving average of $333.15. The firm has a market capitalization of $93.91 billion, a P/E ratio of 27.14, a P/E/G ratio of 1.02 and a beta of 0.53. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.75. The Cigna Group has a 52 week low of $253.95 and a 52 week high of $365.71.

The Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, May 2nd. The health services provider reported $6.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.17 by $0.30. The Cigna Group had a net margin of 1.76% and a return on equity of 17.24%. The business had revenue of $57.25 billion for the quarter, compared to analysts’ expectations of $56.59 billion. During the same period last year, the firm posted $5.41 earnings per share. The firm’s quarterly revenue was up 23.2% compared to the same quarter last year. As a group, research analysts forecast that The Cigna Group will post 28.48 EPS for the current year.

The Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 20th. Investors of record on Tuesday, June 4th were paid a $1.40 dividend. This represents a $5.60 annualized dividend and a yield of 1.69%. The ex-dividend date was Tuesday, June 4th. The Cigna Group’s dividend payout ratio (DPR) is presently 45.98%.

Analyst Upgrades and Downgrades

CI has been the subject of several research analyst reports. Morgan Stanley reiterated an “overweight” rating and set a $392.00 target price (up from $382.00) on shares of The Cigna Group in a research note on Monday, March 4th. Robert W. Baird initiated coverage on shares of The Cigna Group in a research report on Thursday, May 30th. They set an “outperform” rating and a $388.00 price objective for the company. StockNews.com lowered shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, June 12th. Oppenheimer lifted their target price on shares of The Cigna Group from $370.00 to $400.00 and gave the stock an “outperform” rating in a report on Friday, May 3rd. Finally, Baird R W raised shares of The Cigna Group to a “strong-buy” rating in a report on Thursday, May 30th. Two investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $376.20.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.